Horizon Seeks Other Deals As Depomed Thwarts Takeover

Horizon Pharma plc has abandoned its hostile pursuit of Depomed Inc. after a judge in California came down against the Ireland-based bidder both on its argument that a poison pill adopted by Depomed might be unlawful, and on Depomed's motion for an injunction against Horizon's offer for its alleged use of confidential information.

More from Immunological

More from Therapy Areas